Small molecule antagonist to pacap receptor and uses thereof
AssigneeUniversity of Vermont and State Agricultural College
InventorsVictor May, Matthias Brewer, Jianing Li
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Vermont and State Agricultural College
InventorsVictor May, Matthias Brewer, Jianing Li
Estimating the term…
The invention relates to compounds that demonstrate efficacy in blocking PACAP receptors (e.g. PAC1) and associated methods of treating neurological diseases or disorders using the disclosed compounds. The neurological diseases or disorders include, but are not limited to, stress-related diseases (e.g. chronic stress, post-traumatic stress disorder (PTSD), anxiety, or general anxiety disorder), pain-related diseases (e.g. chronic pain, primary headache disorders, or migraines), or addiction (e.g. addiction to a substance (e.g. addiction to cocaine, amphetamines, methamphetamine, methylphenidate, nicotine, alcohol, prescription medication, marijuana, tobacco, or an opioid selected from heroin, fentanyl, codeine, hydrocodone, morphine, oxycodone, hydromorphone, and methadone)).
A compound of Formula (I):
A compound of Formula (II):
A compound of Formula (III):
A compound of Formula (IV):
Dependencies are inferred from the claim text.